10-Q: Horizon Technology Finance Corp Reports First Quarter 2024 Results
Quarterly Report
Horizon Technology Finance Corp's first quarter 2024 results show a net increase in net assets resulting from operations of $8.7 million, or $0.26 per share.
Summary
- Horizon Technology Finance Corp reported a net increase in net assets resulting from operations of $8.7 million, or $0.26 per share, for the first quarter of 2024.
- The company's total investment income was $26.1 million, while total expenses were $13.1 million.
- Net investment income for the quarter was $12.6 million, or $0.38 per share.
- The company's net asset value per common share decreased slightly from $9.71 to $9.64.
- The company declared distributions of $0.38 per share for the quarter.
- The company's weighted average shares outstanding were 33,579,743.
- The company's total portfolio investment assets were $711.1 million at fair value.
- The company had $168.2 million in unfunded commitments to extend credit as of March 31, 2024.
Sentiment
Score: 5
Explanation: The document presents a mixed picture. While the company maintains a strong portfolio and continues to generate income, there are signs of decreased profitability and a slight decrease in net asset value. The company's reliance on debt and the inherent risks of its portfolio companies also contribute to a neutral sentiment.
Positives
- The company generated a net investment income of $12.6 million for the quarter.
- The company's total portfolio investment assets were $711.1 million at fair value.
- The company declared distributions of $0.38 per share for the quarter.
Negatives
- The company's net asset value per common share decreased slightly from $9.71 to $9.64.
- Total investment income decreased by $1.9 million, or 6.8%, to $26.1 million for the three months ended March 31, 2024 as compared to the three months ended March 31, 2023.
- Net unrealized depreciation on investments totaled $4.0 million for the quarter.
Risks
- The company's investments are primarily in development-stage companies, which may have limited operating histories and may experience variation in operating results.
- Many of the company's borrowers may need additional capital to service their debt obligations.
- The company's investments are subject to interest rate risk, and changes in interest rates could affect the fair value of the company's financial instruments.
- The company's investments are subject to credit risk, and the company may experience losses if borrowers default on their obligations.
- The company's investments are subject to market risk, and changes in market conditions could affect the fair value of the company's investments.
- The company's investments are subject to inflation and supply chain risk, which could affect the profitability of the company's portfolio companies.
Future Outlook
The company expects to raise additional equity and debt capital opportunistically as needed and, subject to market conditions, to support its future growth to the extent permitted by the 1940 Act. The company believes that its current cash, cash generated from operations, and funds available from its Credit Facilities will be sufficient to meet its working capital and capital expenditure commitments for at least the next 12 months.
Industry Context
The company operates in the specialty finance sector, focusing on lending to and investing in development-stage companies in the technology, life science, healthcare information and services and sustainability industries. These industries are characterized by high growth potential but also higher risk, which is reflected in the company's investment strategy and portfolio composition.
Comparison to Industry Standards
- The company's weighted average credit rating of 3.1 indicates a moderate level of risk in its debt investment portfolio, which is typical for a BDC focused on venture lending.
- The company's net investment income of $0.38 per share is within the range of other BDCs, but the specific performance is dependent on the portfolio composition and the company's leverage.
- The company's total portfolio investment assets of $711.1 million at fair value is comparable to other BDCs of similar size and focus.
- The company's use of leverage, with an asset coverage of 173%, is within the regulatory limits for BDCs and is a common practice to enhance returns.
Related Party Transactions
- The company has an investment management agreement with Horizon Technology Finance Management LLC, under which the Advisor manages the day-to-day operations of, and provides investment advisory services to, the company.
- The company has an administration agreement with the Advisor to provide administrative services to the company.
Stakeholder Impact
- Shareholders will receive distributions of $0.38 per share for the quarter.
- Shareholders may experience fluctuations in the company's net asset value due to market conditions and investment performance.
- The company's employees and management will continue to manage the company's operations and investments.
- The company's portfolio companies will continue to receive funding and support from the company.
Next Steps
- The company will continue to monitor its portfolio companies and manage its credit risk.
- The company will continue to evaluate opportunities to raise additional capital.
- The company will continue to evaluate opportunities to make new investments in its target industries.
Key Dates
| Date | Description |
|---|---|
| 2010-03-16 | Horizon Technology Finance Corporation was organized as a Delaware corporation. |
| 2010-10-28 | The company completed its initial public offering (IPO). |
| 2011-06-28 | Horizon Credit II LLC was formed as a Delaware limited liability company. |
| 2013-11-04 | The company entered into the Key Facility with KeyBank National Association. |
| 2018-05-09 | Horizon Funding I, LLC (HFI) was formed as a Delaware limited liability company. |
| 2019-05-02 | Horizon Funding 20191 LLC (20191 LLC) was formed as a Delaware limited liability company. |
| 2019-05-15 | Horizon Funding Trust 20191 was formed as a Delaware statutory trust. |
| 2019-08-13 | The company completed a term debt securitization in connection with which an affiliate of the company made an offering of the 2019 Asset-Backed Notes. |
| 2020-04-21 | HSLFI and its subsidiary, HFI, are consolidated by the company. |
| 2021-03-30 | The company issued and sold an aggregate principal amount of $57.5 million of 4.875% notes due in 2026 (the 2026 Notes). |
| 2021-08-02 | The company entered into an At-The-Market (ATM) sales agreement (the 2021 Equity Distribution Agreement). |
| 2022-02-25 | The company amended its NYL Facility to, among other things, reduce the applicable margin used to calculate the credit facilitys interest rate on the company's borrowings above $100.0 million. |
| 2022-06-15 | The company issued and sold an aggregate principal amount of $50.0 million of 6.25% notes due in 2027 (the 2027 Notes). |
| 2022-07-11 | The company sold an additional $7.5 million of the 2027 Notes. |
| 2022-09-30 | Horizon Funding 20221 LLC (20221 LLC) was formed as a Delaware limited liability company. |
| 2022-10-18 | Horizon Funding Trust 20221 was formed as a Delaware statutory trust. |
| 2022-11-09 | The company completed a term debt securitization in connection with which an affiliate of the company made an offering of the 2022 Asset-Backed Notes. |
| 2023-05-24 | The company amended its NYL Facility to, among other things, increase the commitment by $50.0 million. |
| 2023-06-29 | The company amended the Key Facility, among other things, to increase the commitment amount to $150 million. |
| 2023-06-30 | The new Investment Management Agreement became effective. |
| 2023-09-22 | The company terminated the 2021 Equity Distribution Agreement and entered into a new ATM sales agreement (the 2023 Equity Distribution Agreement). |
| 2023-11-22 | The 2019 Asset-Backed Notes were repaid in full. |
| 2024-01-11 | Nexii Building Solutions Inc., and its affiliates, obtained an Initial Order under the Companies Creditors Arrangement Act. |
| 2024-03-31 | End of the reporting period for the first quarter of 2024. |
| 2024-04-26 | The Board extended a previously authorized stock repurchase program. |
Keywords
Venture Lending, Technology, Life Science, Healthcare Information, Sustainability, Debt Investments, Warrants, Business Development Company, BDC, Net Investment Income, Fair Value, Unfunded Commitments
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.